1. Is there a clear-cut demonstration or demarcating line between primary hemostasis and secondary hemostasis or coagulation? Explain your answer in not more than 3 sentences. 2. There are 3 stages in primary hemostasis; platelet adhesion, aggregation and secretion. If one of these is impaired, will there be a production of platelet plug? Defend your answer in not more than 5 sentences.

1. Is there a clear-cut demonstration or demarcating line between primary hemostasis and secondary hemostasis or coagulation? Explain your answer in not more than 3 sentences. 2. There are 3 stages in primary hemostasis; platelet adhesion, aggregation and secretion. If one of these is impaired, will there be a production of platelet plug? Defend your answer in not more than 5 sentences.

An Illustrated Guide To Vet Med Term

4th Edition

ISBN:9781305465763

Author:ROMICH

Publisher:ROMICH

Chapter15: Feed And Protect Me

Section: Chapter Questions

Problem 17MC

See similar textbooks

Similar questions

1. Is there a clear-cut demonstration or demarcating line between primary hemostasis and secondary hemostasis or coagulation? Explain your answer in not more than 3 sentences. 2. There are 3 stages in primary hemostasis; platelet adhesion, aggregation and secretion. If one of these is impaired, will there be a production of platelet plug? Defend your answer in not more than 5 sentences.
1. Is there a clear-cut demonstration or demarcating line between primary hemostasis and secondary hemostasis or coagulation? Explain your answer in not more than 3 sentences.
ANSWER BRIEFLY: 3. Differentiate Bernard Soulier from Glanzmann's disease as to: a. pathology b. appearance of platelets in blood smear c. stage in primary hemostasis impaired 4. Briefly, give the advantage of platelet closure time over bleeding time in not more than 3 sentences.
With the results below, do you think the patient requires a transfusion? Using current guidlines to support your answer , explain your reason. Investigation Result (normal range - female) Haematology Red cell count (x 1012/L) 4.0 (3.8 – 5.8) Haemoglobin (g/L) 123 (115 – 165) White cell count (x 109/L) 8.1 (3.6 – 11.0) neutrophils 2.9 (1.8 – 7.5) lymphocytes 4.5 (1.0 – 4.0) monocytes 0.62 (0.2 – 0.8) eosinophils 0.10 (0.1 – 0.4) basophils 0.02 (0.02 – 0.1) Platelets (x 109/L) 138 (140 – 400) Prothrombin Time (s) 20 (10 – 14) Activated Partial Thromboplastin Time (s) 45 (22 – 36) Biochemistry Serum Bilirubin (µmol/L) 50 (≤21) Serum ALP (IU/L) 300 (30 – 130) Serum AST (IU/L) 527 (≤32) Serum ALT (IU/L) 650 (10 – 35) Serum albumin (g/L) 37 (35 – 50) Urine: Microscopy Faeces: Microscopy WBC <5 per ml No Cryptosporidium seen RBC <5…
What is suspected when the hematocrit has decreased by 4% and the total bilirubin level is increased 5 days after transfusion? Question 8 options: a) Urticarial reaction b) Volume overload c) Delayed hemolytic transfusion reaction d) Acute hemolytic transfusion reaction
A 45-year-old man noticed multiple pinpoint red spots and bruises on his arms and legs. The hematologist confirmed the presence of petechiae, purpura, and ecchymoses on his extremities and ordered a complete blood count, prothrombin time, and partial thromboplastin time. The platelet count was 40 x 109/L, the mean platelet volume was 12.2 fL, and the diameter of platelets on the Wright-stained peripheral blood film appeared to exceed 6 mm. Other complete blood count parameters and the coagulation parameters were within normal limits. A Wright-stained bone marrow aspirate smear revealed 10 to 12 small unlobulated megakaryocytes per low-power microscopic field. Do these signs and symptoms indicate systemic (mucocutaneous) or anatomical (soft tissue) bleeding? Why?
A 45-year-old man noticed multiple pinpoint red spots and bruises on his arms and legs. The hematologist confirmed the presence of petechiae, purpura, and ecchymoses on his extremities and ordered a complete blood count, prothrombin time, and partial thromboplastin time. The platelet count was 40 x 109/L, the mean platelet volume was 12.2 fL, and the diameter of platelets on the Wright-stained peripheral blood film appeared to exceed 6 mm. Other complete blood count parameters and the coagulation parameters were within normal limits. A Wright-stained bone marrow aspirate smear revealed 10 to 12 small unlobulated megakaryocytes per low-power microscopic field. Is the thrombocytopenia the result of inadequate bone marrow production? Explain why. Do these signs and symptoms indicate systemic (mucocutaneous) or anatomical (soft tissue) bleeding? Why?
Which blood product is used in the treatment of DIC? Question 9 options: a) Plasma b) Platelets c) Cryoprecipitate d) All of the above
Please help me answer these in detail Question #1: List the special requirements for collecting blood through intravenous (IV) catheters. Question #2: Differentiate cannulas from fistulas.
1. Give the importance of blood vessels free of plaque/clots. Explain in not more than 3 sentences. 2. If you are a platelet, what will you tell a person regarding your role in his hemostatic mechanism. Explain in not more than 5 sentences.
BACKGROUND A 2-year-old black girl is being seen by the hematologist after her pediatrician found her to be severely anemic with splenomegaly and jaundice. Her mother gives a possible history of a “blood problem” in her family but doesn’t know for sure. Her hemoglobin electrophoresis was normal, and the complete blood count (CBC) revealed a normocytic anemia. The platelet and white blood cell counts are normal. On the peripheral smear, there are many bizarre erythrocytes, including spiculated cells. A diagnosis of pyruvate kinase deficiency is made. Pyruvate kinase deficiency (PKD) can be inherited in an autosomal recessive manner, which means that a child must inherit a gene with the disease-causing mutation from both parents in order for the disorder to be inherited. The PLKR gene regulates the synthesis of the pyruvate kinase enzyme, which is located in the liver and red blood cells. Pyruvate kinase deficiency (PKD) is a rare genetic disorder characterized by the premature…
Compute for the absolute count of patients A and B PATIENT A WBC count = 6 x 109/L Differential count Absolute count Neutrophils = 65% Lymphocytes = 20% Monocytes = 13% Eosinophils = 2% PATIENT B WBC count = 18 x 109/L Differential count Absolute count Neutrophils = 65% Lymphocytes = 20% Monocytes = 10% Eosinophils = 5% Give an impression of their results. (Indicate whether the cells are increased or decreased using the proper terminologies. Indicate also whether the increased or decreased values are absolute or relative)